Telomerase-Derived Peptides for Novel Industrial Applications

Publication ID: 24-11857607_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Telomerase-Derived Peptides for Novel Industrial Applications,” Published Technical Disclosure No. 24-11857607_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857607_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,607.

Summary of the Inventive Concept

This inventive concept expands the use of telomerase-derived peptides with anti-inflammatory effects to novel industrial applications, including agricultural soil treatment, industrial manufacturing processes, 3D printing materials, computer servers, and water pollution remediation.

Background and Problem Solved

The original patent focused on the use of telomerase-derived peptides for treating dermal related inflammatory diseases. However, the anti-inflammatory properties of these peptides have broader potential. The new inventive concept addresses the limitations of the original patent by exploring the application of these peptides in entirely new industries and fields, solving problems such as soil inflammation, machinery wear and tear, print quality issues, server overheating, and water pollution.

Detailed Description of the Inventive Concept

The new inventive concept comprises the use of telomerase-derived peptides with anti-inflammatory effects in various industrial applications. For example, in agricultural soil treatment, the peptides can be administered to reduce inflammation and promote healthy microbial growth. In industrial manufacturing processes, the peptides can be used to reduce wear and tear on machinery and increase overall efficiency. In 3D printing materials, the peptides can be incorporated to reduce inflammation and improve print quality. In computer servers and data storage devices, the peptides can be administered to reduce heat and improve overall performance. Finally, in water pollution remediation, the peptides can be used to reduce inflammation and promote healthy aquatic ecosystems.

Novelty and Inventive Step

The new inventive concept is novel and non-obvious in its application of telomerase-derived peptides to entirely new industries and fields, beyond the original patent's focus on dermal related inflammatory diseases. The inventive step lies in recognizing the broader potential of these peptides and adapting their use to solve specific problems in these new areas.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using different types of peptides, varying the administration methods, or combining the peptides with other compounds to enhance their effects. Variations could also include applying the peptides to other industrial processes, such as textile manufacturing or construction materials.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, manufacturing, 3D printing, computer hardware, and environmental remediation. The market for these applications is substantial, with potential customers including farmers, manufacturers, 3D printing companies, data centers, and government agencies responsible for environmental protection.

CPC Classifications

SectionClassGroup
A A61 A61K38/45
A A23 A23L33/18
A A61 A61K8/64
A A61 A61Q19/00
C C07 C07K7/08
C C07 C07K14/4703
C C12 C12N9/0069
C C12 C12N9/0083
C C12 C12Y113/11
C C12 C12Y114/99001
C C12 C12Y207/07049
A A23 A23V2002/00
A A61 A61K38/00
Y Y02 Y02A50/30

Field of Art

Biotechnology and pharmaceutical sciences, with expertise in peptide-based therapeutic and industrial applications, specifically focused on anti-inflammatory peptide technologies and their potential cross-industry implementations

Person of Ordinary Skill (PHOSITA) Profile

A researcher or engineer with advanced degrees in biotechnology, biochemistry, or chemical engineering, possessing knowledge of peptide structure, function, and adaptable applications across multiple technical domains

Obviousness Rationale

A person of ordinary skill would recognize that the anti-inflammatory properties of telomerase-derived peptides disclosed in the source patent inherently suggest broader potential applications beyond dermal treatments. The fundamental mechanism of reducing inflammation provides a clear technical pathway for exploring alternative industrial uses, with predictable and reproducible results across different technological contexts.

Obvious Combinations & Variations

Source Patent Element
Anti-inflammatory peptide composition with flexible administration methods (oral, transdermal, intravenous)
PTD Variation
Applying peptides to agricultural soil treatment and microbial ecosystem management
Obviousness Reasoning
The source patent demonstrates peptides can be administered through multiple routes, suggesting adaptability to different environmental contexts with predictable anti-inflammatory effects
Source Patent Element
Peptide concentration ranges of 0.1 μg/mg to 1 mg/mg
PTD Variation
Scaling peptide concentrations for industrial manufacturing and 3D printing material enhancement
Obviousness Reasoning
Established concentration protocols from medical applications can be directly translated to industrial processes using standard scaling and dilution techniques
Source Patent Element
Treatment of inflammatory conditions through targeted peptide intervention
PTD Variation
Reducing inflammation in computer server systems and mechanical equipment
Obviousness Reasoning
The fundamental anti-inflammatory mechanism is technically transferable across biological and mechanical systems, representing a predictable extension of the original peptide technology
Source Patent Element
Peptide composition for addressing localized inflammatory responses
PTD Variation
Water pollution remediation through inflammation reduction in aquatic ecosystems
Obviousness Reasoning
The source patent's core principle of targeted inflammatory intervention can be logically extended to environmental management scenarios with similar mechanistic approaches
Source Patent Element
Isolated peptide with specific anti-inflammatory properties
PTD Variation
Incorporating peptides into diverse material compositions for performance enhancement
Obviousness Reasoning
The inherent chemical properties of the peptides suggest broad compatibility and potential for material modification across multiple technological domains
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857607 and the published technical disclosure, a person of ordinary skill in the art would find the proposed industrial applications of anti-inflammatory peptides to be obvious variations of the existing technological framework, thereby rendering potential claims to such applications unpatentable under 35 U.S.C. § 103 as predictable extensions of the prior art.

Original Patent Information

Patent NumberUS 11,857,607
TitleAnti-inflammatory peptides and composition comprising the same
Assignee(s)GemVax & KAEL Co., Ltd.